Toggle navigation
Home
About Us
Meet the Team
Our Work with NICE
Clients
Pharmaceutical Companies
Device Companies
National Health Organisations
Local Health and Public Sector Organisations
Other Organisations
Training
Resources
Publications
Webinars
Glossary
Case Studies
Tools and Models
Contact Us
YHEC Careers
Sign up to the newsletter
University of York
A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese Type 2 diabetes population
Back to all publications
